| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.3M | — | +47.9% |
| Cost of Revenue | $2.5M | — | +33.4% |
| Gross Profit | $854K | — | +115.5% |
| R&D Expense | $205K | — | -44.4% |
| SG&A Expense | $6.2M | — | +46.7% |
| Operating Income | -$5.7M | — | -35.0% |
| Net Income | -$5.8M | — | -30.7% |
| EPS (Basic) | -$0.54 | — | +48.6% |
| EPS (Diluted) | -$0.54 | — | +48.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $567K | -90.5% | -88.8% |
| Accounts Receivable | $480K | -4.7% | +606.7% |
| Inventory | $11.6M | +22.0% | +103.0% |
| Current Assets | $13.5M | -19.8% | +17.6% |
| Total Assets | $27.9M | -9.2% | +4.6% |
| Current Liabilities | $6.9M | +2.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | -114.5% |
| Capital Expenditures | $104K | — | -48.6% |
| Investing Cash Flow | -$104K | — | +77.4% |
| Financing Cash Flow | $3.0M | — | -34.2% |
| Free Cash Flow | -$8.3M | — | -106.3% |
| +95.8% |
| Long-term Debt | $3.4M | +28.5% | +9.5% |
| Total Liabilities | $7.9M | +0.8% | +20.9% |
| Stockholders' Equity | $20.0M | -12.7% | -0.7% |